Emile, S. H.
Horesh, N.
Strassmann, V.
Garoufalia, Z.
Gefen, R.
Zhou, P.
Ray-Offor, E.
Dasilva, G.
Wexner, S. D. https://orcid.org/0000-0001-8046-5753
Article History
Received: 15 November 2022
Accepted: 24 January 2023
First Online: 17 February 2023
Declarations
:
: Dr. Wexner reports receiving consulting fees from ICON Language Services, IntuitiveSurgical, Stryker, Medtronic, Takeda, ARC/Corvus, Astellas, Baxter, Olympus, Livsmed, GI Supply, and Leading BioSciences and receiving royalties from Medtronic, Intuitive Surgical, Karl Storz Endoscopy America Inc, and Unique Surgical Innovations, LLC.
: Data used in the study were derived from an IRB-approved (FLA 14-039) database of the Department of Colorectal Surgery, Cleveland Clinic Florida.
: Informed consent to particpate in the study was waived due to the retrospective nature of the study.